These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 6294517

  • 1. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.
    Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Propper RD, Mills JA, Weiner HL.
    N Engl J Med; 1983 Jan 27; 308(4):173-80. PubMed ID: 6294517
    [Abstract] [Full Text] [Related]

  • 2. Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients.
    Carter JL, Hafler DA, Dawson DM, Orav J, Weiner HL.
    Neurology; 1988 Jul 27; 38(7 Suppl 2):9-14. PubMed ID: 2838768
    [Abstract] [Full Text] [Related]

  • 3. [Early results of the treatment of chronic progressive forms of multiple sclerosis with cyclophosphamide and ACTH].
    Wender M, Tokarz-Kupczyk E, Mularek O.
    Neurol Neurochir Pol; 1988 Jul 27; 22(5):399-403. PubMed ID: 2854886
    [Abstract] [Full Text] [Related]

  • 4. [Late results of the treatment of the chronic progressive form of multiple sclerosis by intensive immunosuppression].
    Wender M, Tokarz-Kupczyk E, Mularek O.
    Neurol Neurochir Pol; 1989 Jul 27; 23(3):188-92. PubMed ID: 2561379
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies.
    Dawson DM, Carter JL, Hafler DA, Weiner HL.
    Riv Neurol; 1987 Jul 27; 57(2):88-91. PubMed ID: 3039645
    [Abstract] [Full Text] [Related]

  • 6. [Intensive immunosuppression in progressive multiple sclerosis. An open study comparing 3 groups: cyclophosphamide, cyclophosphamide-plasmapheresis and control subjects. Results after 3 years].
    Trouillas P, Neuschwander P, Nighoghossian N, Adeleine P, Tremisi P.
    Rev Neurol (Paris); 1989 Jul 27; 145(5):369-77. PubMed ID: 2662340
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of multiple sclerosis.
    McFarlin DE.
    N Engl J Med; 1983 Jan 27; 308(4):215-7. PubMed ID: 6294519
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study.
    Glöckner WM, Sieberth HG, Wichmann HE, Backes E, Bambauer R, Boesken WH, Bohle A, Daul A, Graben N, Keller F.
    Clin Nephrol; 1988 Jan 27; 29(1):1-8. PubMed ID: 3289804
    [Abstract] [Full Text] [Related]

  • 14. Cyclophosphamide in chronic progressive multiple sclerosis. Maintenance vs nonmaintenance therapy.
    Goodkin DE, Plencner S, Palmer-Saxerud J, Teetzen M, Hertsgaard D.
    Arch Neurol; 1987 Aug 27; 44(8):823-7. PubMed ID: 2820359
    [Abstract] [Full Text] [Related]

  • 15. The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
    Lancet; 1991 Feb 23; 337(8739):441-6. PubMed ID: 1671468
    [Abstract] [Full Text] [Related]

  • 16. Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis.
    Goodkin DE, Rudick RA, VanderBrug Medendorp S, Daughtry MM, Schwetz KM, Fischer J, Van Dyke C.
    Ann Neurol; 1995 Jan 23; 37(1):30-40. PubMed ID: 7818255
    [Abstract] [Full Text] [Related]

  • 17. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ.
    Clin Ther; 2006 Apr 23; 28(4):461-74. PubMed ID: 16750460
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC.
    Am J Med; 2006 Apr 23; 119(4):355.e25-33. PubMed ID: 16564783
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.